Annual ROE
-2.94%
+41.57%+93.39%
December 31, 2023
Summary
- As of February 12, 2025, TRDA annual return on equity is -2.94%, with the most recent change of +41.57% (+93.39%) on December 31, 2023.
- During the last 3 years, TRDA annual ROE has fallen by -66.87% (-104.60%).
- TRDA annual ROE is now -104.60% below its all-time high of 63.93%, reached on December 31, 2020.
Performance
TRDA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
17.06%
-20.37%-54.42%
September 30, 2024
Summary
- As of February 12, 2025, TRDA quarterly return on equity is 17.06%, with the most recent change of -20.37% (-54.42%) on September 30, 2024.
- Over the past year, TRDA quarterly ROE has increased by +26.78% (+275.51%).
- TRDA quarterly ROE is now -76.21% below its all-time high of 71.72%, reached on September 30, 2021.
Performance
TRDA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TRDA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +93.4% | +275.5% |
| 3 y3 years | -104.6% | +144.1% |
| 5 y5 years | -108.9% | +144.1% |
TRDA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.4% | -54.4% | +118.6% |
| 5 y | 5-year | -104.6% | +93.4% | -76.2% | +118.6% |
| alltime | all time | -104.6% | +93.4% | -76.2% | +118.6% |
Entrada Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 17.06%(-54.4%) |
| Jun 2024 | - | 37.43%(+280.8%) |
| Mar 2024 | - | 9.83%(-434.4%) |
| Dec 2023 | -2.94%(-93.4%) | -2.94%(-69.8%) |
| Sep 2023 | - | -9.72%(-74.0%) |
| Jun 2023 | - | -37.34%(+9.2%) |
| Mar 2023 | - | -34.19%(-11.5%) |
| Dec 2022 | -44.51% | -38.65%(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -33.20%(-18.9%) |
| Jun 2022 | - | -40.93%(-29.4%) |
| Mar 2022 | - | -58.00%(-36.8%) |
| Dec 2021 | -17.13%(-126.8%) | -91.84%(-228.1%) |
| Sep 2021 | - | 71.72%(+6.2%) |
| Jun 2021 | - | 67.55%(+16.6%) |
| Mar 2021 | - | 57.95%(+53.5%) |
| Dec 2020 | 63.93%(+94.5%) | 37.75% |
| Dec 2019 | 32.87% | - |
FAQ
- What is Entrada Therapeutics annual return on equity?
- What is the all time high annual ROE for Entrada Therapeutics?
- What is Entrada Therapeutics annual ROE year-on-year change?
- What is Entrada Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly ROE year-on-year change?
What is Entrada Therapeutics annual return on equity?
The current annual ROE of TRDA is -2.94%
What is the all time high annual ROE for Entrada Therapeutics?
Entrada Therapeutics all-time high annual return on equity is 63.93%
What is Entrada Therapeutics annual ROE year-on-year change?
Over the past year, TRDA annual return on equity has changed by +41.57% (+93.39%)
What is Entrada Therapeutics quarterly return on equity?
The current quarterly ROE of TRDA is 17.06%
What is the all time high quarterly ROE for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly return on equity is 71.72%
What is Entrada Therapeutics quarterly ROE year-on-year change?
Over the past year, TRDA quarterly return on equity has changed by +26.78% (+275.51%)